Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Gerretsen

Showing results (161-170 of 196) with videos related to

Pageof 20
Sort By:
Schizophrenia Bulletin|April 25, 2026
The Immediate and Sustained Effects of Multi-Session Biparietal Transcranial Direct Current Stimulation on Insight in SchizophreniaJianmeng Song, Julia Kim, Edgardo Carmona-Torres, et al.
Schizophrenia (Heidelberg, Germany)|April 29, 2023
Cortical thinning in relation to impaired insight into illness in patients with treatment resistant schizophreniaJulia Kim, Jianmeng Song, Yasaman Kambari, et al.
Schizophrenia Research|February 5, 2022
Decision tree classification of cognitive functions with D<sub>2</sub> receptor occupancy and illness severity in late-life schizophreniaKeisuke Kusudo, Ryo Ochi, Shinichiro Nakajima, et al.
Schizophrenia Research|March 12, 2015
Dopamine D₂/₃ receptor availability in the striatum of antipsychotic-free older patients with schizophrenia-A [¹¹C]-raclopride PET studyShinichiro Nakajima, Fernando Caravaggio, David C Mamo, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 22, 2019
Modulation of brain activity with transcranial direct current stimulation: Targeting regions implicated in impaired illness awareness in schizophreniaJulia Kim, Eric Plitman, Shinichiro Nakajima, et al.
Schizophrenia Bulletin Open|May 10, 2021
Glutathione Levels and Glutathione-Glutamate Correlation in Patients With Treatment-Resistant SchizophreniaYusuke Iwata, Shinichiro Nakajima, Eric Plitman, et al.
Therapeutic Advances in Psychopharmacology|May 23, 2022
Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping reviewRaghunath Singh, Nicolette Stogios, Emily Smith, et al.
Frontiers in Psychiatry|December 21, 2018
Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in SchizophreniaNicole E MacKenzie, Chantel Kowalchuk, Sri Mahavir Agarwal, et al.
International Journal of Geriatric Psychiatry|November 8, 2017
Amotivation is associated with smaller ventral striatum volumes in older patients with schizophreniaFernando Caravaggio, Gagan Fervaha, Yusuke Iwata, et al.
International Psychogeriatrics|May 13, 2022
Impact of standardizing care for agitation in dementia using an integrated care pathway on an inpatient geriatric psychiatry unitSanjeev Kumar, Amruta Shanbhag, Amer M Burhan, et al.
Pageof 20

Showing results (161-170 of 196) with videos related to

Sort By:
Pageof 20
Schizophrenia Bulletin|April 25, 2026
The Immediate and Sustained Effects of Multi-Session Biparietal Transcranial Direct Current Stimulation on Insight in SchizophreniaJianmeng Song, Julia Kim, Edgardo Carmona-Torres, et al.
Schizophrenia (Heidelberg, Germany)|April 29, 2023
Cortical thinning in relation to impaired insight into illness in patients with treatment resistant schizophreniaJulia Kim, Jianmeng Song, Yasaman Kambari, et al.
Schizophrenia Research|February 5, 2022
Decision tree classification of cognitive functions with D<sub>2</sub> receptor occupancy and illness severity in late-life schizophreniaKeisuke Kusudo, Ryo Ochi, Shinichiro Nakajima, et al.
Schizophrenia Research|March 12, 2015
Dopamine D₂/₃ receptor availability in the striatum of antipsychotic-free older patients with schizophrenia-A [¹¹C]-raclopride PET studyShinichiro Nakajima, Fernando Caravaggio, David C Mamo, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 22, 2019
Modulation of brain activity with transcranial direct current stimulation: Targeting regions implicated in impaired illness awareness in schizophreniaJulia Kim, Eric Plitman, Shinichiro Nakajima, et al.
Schizophrenia Bulletin Open|May 10, 2021
Glutathione Levels and Glutathione-Glutamate Correlation in Patients With Treatment-Resistant SchizophreniaYusuke Iwata, Shinichiro Nakajima, Eric Plitman, et al.
Therapeutic Advances in Psychopharmacology|May 23, 2022
Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping reviewRaghunath Singh, Nicolette Stogios, Emily Smith, et al.
Frontiers in Psychiatry|December 21, 2018
Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in SchizophreniaNicole E MacKenzie, Chantel Kowalchuk, Sri Mahavir Agarwal, et al.
International Journal of Geriatric Psychiatry|November 8, 2017
Amotivation is associated with smaller ventral striatum volumes in older patients with schizophreniaFernando Caravaggio, Gagan Fervaha, Yusuke Iwata, et al.
International Psychogeriatrics|May 13, 2022
Impact of standardizing care for agitation in dementia using an integrated care pathway on an inpatient geriatric psychiatry unitSanjeev Kumar, Amruta Shanbhag, Amer M Burhan, et al.
Pageof 20